Examining how treating hepatitis C affects incarcerated individuals with HIV and hepatitis C
The Impact of HCV Treatment in HIV/HCV coinfected and HCV monoinfected Incarcerated Persons on HCV Elimination
This study looks at how hepatitis C treatment affects people in prison who have either hepatitis C alone or also have HIV, and it aims to find out what makes it hard for them to get the treatment they need so we can help more people get better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10910101 on NIH RePORTER |
What this research studies
This research investigates the effects of hepatitis C (HCV) treatment on individuals who are incarcerated and either coinfected with HIV or solely infected with HCV. The study aims to understand the barriers that prevent these individuals from receiving effective treatment, including high costs and lack of awareness about their infection status. By focusing on this vulnerable population, the research seeks to identify strategies for improving access to HCV treatment and ultimately achieving HCV elimination. The methodology includes analyzing data from correctional facilities and assessing treatment outcomes among participants.
Who could benefit from this research
Good fit: Ideal candidates for this research are incarcerated individuals who are either coinfected with HIV and hepatitis C or solely infected with hepatitis C.
Not a fit: Patients who are not incarcerated or those who do not have hepatitis C or HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment access and health outcomes for incarcerated individuals suffering from hepatitis C and HIV.
How similar studies have performed: Previous research has shown success in improving treatment access for hepatitis C in similar populations, indicating that this approach has potential for impactful outcomes.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Irvin, Risha — Johns Hopkins University
- Study coordinator: Irvin, Risha
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.